BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 35245608)

  • 1. Heterozygous Dnmt3a R878C induces expansion of quiescent hematopoietic stem cell pool.
    Higo T; Suzuki Y; Sato M; Koya J; Mizuno H; Miyauchi M; Masamoto Y; Kataoka K; Sumitomo Y; Tsuruta-Kishino T; Sato T; Kurokawa M
    Exp Hematol; 2022 May; 109():45-54. PubMed ID: 35245608
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Txnip Enhances Fitness of Dnmt3a-Mutant Hematopoietic Stem Cells via p21.
    Zhang CR; Ostrander EL; Kukhar O; Mallaney C; Sun J; Haussler E; Celik H; Koh WK; King KY; Gontarz P; Challen GA
    Blood Cancer Discov; 2022 May; 3(3):220-239. PubMed ID: 35394496
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of Dnmt3a Immortalizes Hematopoietic Stem Cells In Vivo.
    Jeong M; Park HJ; Celik H; Ostrander EL; Reyes JM; Guzman A; Rodriguez B; Lei Y; Lee Y; Ding L; Guryanova OA; Li W; Goodell MA; Challen GA
    Cell Rep; 2018 Apr; 23(1):1-10. PubMed ID: 29617651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic infection drives Dnmt3a-loss-of-function clonal hematopoiesis via IFNγ signaling.
    Hormaechea-Agulla D; Matatall KA; Le DT; Kain B; Long X; Kus P; Jaksik R; Challen GA; Kimmel M; King KY
    Cell Stem Cell; 2021 Aug; 28(8):1428-1442.e6. PubMed ID: 33743191
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tissue-Biased Expansion of DNMT3A-Mutant Clones in a Mosaic Individual Is Associated with Conserved Epigenetic Erosion.
    Tovy A; Reyes JM; Gundry MC; Brunetti L; Lee-Six H; Petljak M; Park HJ; Guzman AG; Rosas C; Jeffries AR; Baple E; Mill J; Crosby AH; Sency V; Xin B; Machado HE; Castillo D; Weitzel JN; Li W; Stratton MR; Campbell PJ; Wang H; Sanders MA; Goodell MA
    Cell Stem Cell; 2020 Aug; 27(2):326-335.e4. PubMed ID: 32673568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inflammatory signals from fatty bone marrow support DNMT3A driven clonal hematopoiesis.
    Zioni N; Bercovich AA; Chapal-Ilani N; Bacharach T; Rappoport N; Solomon A; Avraham R; Kopitman E; Porat Z; Sacma M; Hartmut G; Scheller M; Muller-Tidow C; Lipka D; Shlush E; Minden M; Kaushansky N; Shlush LI
    Nat Commun; 2023 Apr; 14(1):2070. PubMed ID: 37045808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hotspot DNMT3A mutations in clonal hematopoiesis and acute myeloid leukemia sensitize cells to azacytidine via viral mimicry response.
    Scheller M; Ludwig AK; Göllner S; Rohde C; Krämer S; Stäble S; Janssen M; Müller JA; He L; Bäumer N; Arnold C; Gerß J; Schönung M; Thiede C; Niederwieser C; Niederwieser D; Serve H; Berdel WE; Thiem U; Hemmerling I; Leuschner F; Plass C; Schlesner M; Zaugg J; Milsom MD; Trumpp A; Pabst C; Lipka DB; Müller-Tidow C
    Nat Cancer; 2021 May; 2(5):527-544. PubMed ID: 35122024
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CRISPR-Mediated Gene Editing to Assess the Roles of Tet2 and Dnmt3a in Clonal Hematopoiesis and Cardiovascular Disease.
    Sano S; Oshima K; Wang Y; Katanasaka Y; Sano M; Walsh K
    Circ Res; 2018 Jul; 123(3):335-341. PubMed ID: 29728415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Divergent Effects of Dnmt3a and Tet2 Mutations on Hematopoietic Progenitor Cell Fitness.
    Ostrander EL; Kramer AC; Mallaney C; Celik H; Koh WK; Fairchild J; Haussler E; Zhang CRC; Challen GA
    Stem Cell Reports; 2020 Apr; 14(4):551-560. PubMed ID: 32220332
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dnmt3a-null hematopoietic stem and progenitor cells expand after busulfan treatment.
    Chen J; Matatall KA; Feng X; Hormaechea-Agulla D; Maharjan M; Young N; King KY
    Exp Hematol; 2020 Nov; 91():39-45.e2. PubMed ID: 32961298
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single-cell multi-omics of human clonal hematopoiesis reveals that DNMT3A R882 mutations perturb early progenitor states through selective hypomethylation.
    Nam AS; Dusaj N; Izzo F; Murali R; Myers RM; Mouhieddine TH; Sotelo J; Benbarche S; Waarts M; Gaiti F; Tahri S; Levine R; Abdel-Wahab O; Godley LA; Chaligne R; Ghobrial I; Landau DA
    Nat Genet; 2022 Oct; 54(10):1514-1526. PubMed ID: 36138229
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Perturbed hematopoiesis in individuals with germline DNMT3A overgrowth Tatton-Brown-Rahman syndrome.
    Tovy A; Rosas C; Gaikwad AS; Medrano G; Zhang L; Reyes JM; Huang YH; Arakawa T; Kurtz K; Conneely SE; Guzman AG; Aguilar R; Gao A; Chen CW; Kim JJ; Carter MT; Lasa-Aranzasti A; Valenzuela I; Van Maldergem L; Brunetti L; Hicks MJ; Marcogliese AN; Goodell MA; Rau RE
    Haematologica; 2022 Apr; 107(4):887-898. PubMed ID: 34092059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miR-29a maintains mouse hematopoietic stem cell self-renewal by regulating Dnmt3a.
    Hu W; Dooley J; Chung SS; Chandramohan D; Cimmino L; Mukherjee S; Mason CE; de Strooper B; Liston A; Park CY
    Blood; 2015 Apr; 125(14):2206-16. PubMed ID: 25634742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Haploinsufficiency for DNA methyltransferase 3A predisposes hematopoietic cells to myeloid malignancies.
    Cole CB; Russler-Germain DA; Ketkar S; Verdoni AM; Smith AM; Bangert CV; Helton NM; Guo M; Klco JM; O'Laughlin S; Fronick C; Fulton R; Chang GS; Petti AA; Miller CA; Ley TJ
    J Clin Invest; 2017 Oct; 127(10):3657-3674. PubMed ID: 28872462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hematopoietic differentiation persists in human iPSCs defective in de novo DNA methylation.
    Cypris O; Franzen J; Frobel J; Glück P; Kuo CC; Schmitz S; Nüchtern S; Zenke M; Wagner W
    BMC Biol; 2022 Jun; 20(1):141. PubMed ID: 35705990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutant ASXL1 induces age-related expansion of phenotypic hematopoietic stem cells through activation of Akt/mTOR pathway.
    Fujino T; Goyama S; Sugiura Y; Inoue D; Asada S; Yamasaki S; Matsumoto A; Yamaguchi K; Isobe Y; Tsuchiya A; Shikata S; Sato N; Morinaga H; Fukuyama T; Tanaka Y; Fukushima T; Takeda R; Yamamoto K; Honda H; Nishimura EK; Furukawa Y; Shibata T; Abdel-Wahab O; Suematsu M; Kitamura T
    Nat Commun; 2021 Mar; 12(1):1826. PubMed ID: 33758188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Functional role of DNMT3A mutation in acute myeloid leukemia].
    Koya J; Kurokawa M
    Rinsho Ketsueki; 2018; 59(5):602-610. PubMed ID: 29877252
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dnmt3a regulates myeloproliferation and liver-specific expansion of hematopoietic stem and progenitor cells.
    Guryanova OA; Lieu YK; Garrett-Bakelman FE; Spitzer B; Glass JL; Shank K; Martinez AB; Rivera SA; Durham BH; Rapaport F; Keller MD; Pandey S; Bastian L; Tovbin D; Weinstein AR; Teruya-Feldstein J; Abdel-Wahab O; Santini V; Mason CE; Melnick AM; Mukherjee S; Levine RL
    Leukemia; 2016 May; 30(5):1133-42. PubMed ID: 26710888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oridonin inhibits DNMT3A R882 mutation-driven clonal hematopoiesis and leukemia by inducing apoptosis and necroptosis.
    Liao M; Dong Q; Chen R; Xu L; Jiang Y; Guo Z; Xiao M; He W; Cao C; Hu R; Sun W; Jiang H; Wang J
    Cell Death Discov; 2021 Oct; 7(1):297. PubMed ID: 34663800
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence and dynamics of clonal hematopoiesis caused by leukemia-associated mutations in elderly individuals without hematologic disorders.
    Midic D; Rinke J; Perner F; Müller V; Hinze A; Pester F; Landschulze J; Ernst J; Gruhn B; Matziolis G; Heidel FH; Hochhaus A; Ernst T
    Leukemia; 2020 Aug; 34(8):2198-2205. PubMed ID: 32457355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.